Article Information
History
- February 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Natalie Bruiners1,3,
- Valentina Guerrini1,3,
- Rahul Ukey1,
- Ryan Dikdan1,
- Jason Yang4,5,
- Pankaj Kumar Mishra1,
- Alberta Onyuka2,
- Deborah Handler2,
- Joshua Vieth6,
- Mary Carayannopulos7,
- Shuang Guo8,
- Maressa Pollen7,
- Abraham Pinter1,3,
- Sanjay Tyagi1,3,
- Daniel Feingold9,
- Claire Philipp8,
- Steven Libutti6,‡ and
- Maria Laura Gennaro1,3,‡
- 1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
- 2Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
- 3Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
- 4Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ 07103
- 5Center for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ 07103
- 6Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08903
- 7Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
- 8Division of Hematology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
- 9Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
- ↵‡Corresponding Authors: steven.libutti{at}cinj.rutgers.edu; marila.gennaro{at}rutgers.edu
Posted February 03, 2022.
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
